On Demand: Preventing Disease and Improving Outcomes Through the Early Detection of PAD-Presentation Slides

Presentation Slides

Pdf Summary

The document discusses the importance of early detection of Peripheral Arterial Disease (PAD), a progressive and preventable condition that often goes undertreated. It highlights the significant impact of PAD on veterans, with high rates of amputations, particularly in those with diabetes. The VA has implemented the PAVE program to address this issue, emphasizing the need for timely referrals and follow-up care.<br /><br />The text stresses the limitations of Ankle-Brachial Index (ABI) testing for PAD detection and introduces QuantaFlo PAD as a quicker, easier, and more accurate alternative. Case presentations illustrate how early detection through QuantaFlo testing led to timely interventions and improved outcomes for patients.<br /><br />Guidelines from organizations like the American Diabetes Association and the American Heart Association/ American College of Cardiology provide recommendations for PAD testing in at-risk populations. The document also advocates for community screening programs to improve detection rates and reduce associated risks.<br /><br />The Lebanon VA's approach to PAD detection involves screening with QuantaFlo in podiatry and wound clinics, resulting in more timely referrals for interventions. The document concludes by outlining the benefits of early PAD detection, such as closing gaps in care, improving outcomes, and increasing patient engagement in treatment plans.<br /><br />Overall, the document emphasizes the importance of early detection through efficient screening methods like QuantaFlo PAD to prevent adverse outcomes associated with PAD, particularly in high-risk populations like veterans.

Keywords

Peripheral Arterial Disease

PAD

early detection

veterans

PAVE program

Ankle-Brachial Index

QuantaFlo PAD

American Diabetes Association

American Heart Association

community screening programs